Based on these results we examined a separate cohort of A-T subjects who had baseline serum IL6 and IL8 measured previously to determine if an association existed between higher serum IL6 and IL8 levels and subsequent development of malignancy and/or death. The gene discussed is IL6; the disease is cancer.